In the 4T1 tumor model, a significant reduction in lung metastasis, and a corresponding increase in overall survival, was observed only when OX40L-FP and MVA-Twist-TRICOM were administered together (Figure 3B and 3C). Here, TNFSF4 is linked to neoplasm.